Key facts
- It has raised $3.8M; the latest was Seed Round ($3.8M) in Aug 2025.
- Notable investors include Entrepreneurs First, Air Street Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Delfa
- ·The full record, as it builds
Funding rounds
No funding rounds for Delfa are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Delfa
Developer of an artificial intelligence-powered patient enrollment platform intended to streamline clinical trial recruitment. The company specializes in automating patient pre-screening, scheduling, and engagement through voice, chat, and text, enabling clinical research sites to scale operations, reduce drop-off, and meet aggressive enrollment timelines without increasing headcount.
- Sector
- Information Technology
- HQ
- San Francisco, CA, United States
- Founded
- 2024
- Employees
- 8
- Website
- delfa.ai/
- Ownership
- Privately Held (backing)
Delfa doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Delfa shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Delfa in its N-PORT filings yet. We sweep new filings monthly.